Considerations for Patient Diversity in Cardiovascular Clinical Trials

Patient diversity in clinical research populations has become a strategic focus of stakeholders throughout the industry and by regulatory authorities throughout the world. There are many common challenges in the recruitment and retention of diverse populations for participation in clinical trials. But, with the right strategy, an ongoing commitment to ensuring representation and a collaborative effort between the CRO, the sponsor and investigative sites, representative diversity in trial populations can be achieved. The key to achieving representative patient diversity in clinical trials is to understand the importance of selecting the correct mix of diversity strategies to create a nuanced, protocol-specific diversity initiative.

Join the featured speakers as they discuss challenges and considerations surrounding the recruitment and retention of diverse patient populations to ensure appropriate representation in clinical research.

Speakers

Sara Sampaio, MD, CCRP, Manager, Patient Recruitment, Medpace

Dr. Sampaio has over eight years’ experience in patient recruitment management at the site level. She has managed a global team of strategic partners, support staff and vendors for multimillion-dollar global marketing, patient recruitment and patient retention campaigns. She received her medical degree from Federal University of Bahia in Salvador, Brazil.

Message Presenter

Hansie M. Mathelier, MD, FACC, Clinical Assistant Professor of Medicine, Penn Medicine

Dr. Mathelier is a cardiologist in Philadelphia, Pennsylvania and is affiliated with multiple hospitals in the area, including Hospitals of the University of Pennsylvania-Penn Presbyterian and Penn Presbyterian Medical Center. She received her medical degree from Johns Hopkins University School of Medicine and has been in practice for 17 years.

Message Presenter

Satya Shreenivas, MD, Medical Director, Medpace

Dr. Shreenivas is an interventional cardiologist bringing over ten years of experience in clinical practice, academia and clinical research. He serves as Director of the University of Cincinnati HLVI Center for Structural and Adult Congenital Heart Disease and Section Head of the UC Catheterization Lab.

Message Presenter